Tivic Health Systems Stock (NASDAQ:TIVC)

Revenue Ownership Financials Chart Transcripts

Previous Close

$0.21

52W Range

$0.20 - $2.24

50D Avg

$0.27

200D Avg

$0.53

Market Cap

$1.66M

Avg Vol (3M)

$5.63M

Beta

2.41

Div Yield

-

TIVC Company Profile

Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

9

IPO Date

Nov 11, 2021

Website

TIVC Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/Service	Dec 23	Dec 22
Shipping and Handling	$3.00K	$3.00K

Fiscal year ends in Dec 23 | Currency in USD

TIVC Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	$1.18M	$1.84M	$1.17M
Operating Income	$-8.24M	$-10.10M	$-5.63M
Net Income	$-8.24M	$-10.10M	$-8.49M
EBITDA	$-8.06M	$-10.10M	$-5.45M
Basic EPS	$-10.40	$-104.37	$-243.16
Diluted EPS	$-10.40	$-104.37	$-243.15

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts

Q3 24Nov 14, 24 | 6:20 PM

Q2 24Aug 15, 24 | 3:25 AM

Q1 24May 15, 24 | 12:00 AM

Peer Comparison

Ticker	Company
RPID	Rapid Micro Biosystems, Inc.
NUWE	Nuwellis, Inc.
BBLG	Bone Biologics Corporation
RSLS	ReShape Lifesciences Inc.
BJDX	Bluejay Diagnostics, Inc.
HSCS	Heart Test Laboratories, Inc.
SINT	Sintx Technologies, Inc.
TNON	Tenon Medical, Inc.
VVOS	Vivos Therapeutics, Inc.
NAOV	NanoVibronix, Inc.